Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-17-002800
Filing Date
2017-03-22
Accepted
2017-03-22 17:27:37
Documents
2
Period of Report
2017-03-22
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A - CHANGES IN REGISTRANTS CERTIFYING ACCOUNTANT a8k-changeofauditorsupdate.htm 8-K/A 27138
2 EXHIBIT 16.1 exhibit161lettertothesec-k.htm EX-16.1 4531
  Complete submission text file 0001628280-17-002800.txt   32762
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K/A | Act: 34 | File No.: 001-33637 | Film No.: 17707569
SIC: 2834 Pharmaceutical Preparations